jinkō: the first collaborative clinical trial simulation platform
Nova has built the first end-to-end solution for clinical trial simulation: the jinkō platform. Using disease models based on scientific literature review and virtual population tools, you can run multiple simulations to help identify the best clinical trial design.
In silico clinical trials with virtual populations help accelerate access to new drugs
In silico modeling enhances clinical trials. Unlike regular clinical trials, in silico clinical trials enable researchers to explore an almost unlimited number of hypotheses. Mechanistic modeling encompasses more available knowledge than other in silico approaches. It can be useful even when data is limited.